REG - Accrol Group Hldgs - PDMR Dealings
RNS Number : 6151LAccrol Group Holdings PLC14 January 202114 January 2021
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
Accrol Group Holdings plc
(the "Company")
AIM: ACRL
PDMR Dealings
Accrol Group Holdings plc, a leading independent tissue converter in the UK, announces that as a result of the Company releasing its half-year results for the six months ended 31 October 2020, certain shares held by PDMRs have ceased to be locked in and as a result the following PDMR dealings have occurred.
PDMR
Number of ordinary shares held pre dealing
Number of ordinary shares sold
Number of ordinary shares held post dealing
% of issued share capital held post dealing
Gareth Jenkins
5,598,632
1,333,000
4,265,632
1.37%
Mark Dewhurst
1,489,975
444,000
1,045,975
0.34%
Graham Cox
683,970
333,000
350,970
0.11%
Further details of the PDMR dealings are included below.
For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman
Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Zeus Capital Limited (Nominated Adviser & Broker)
Dan Bate / Jordan Warburton
Tel: +44 (0) 161 831 1512
Dominic King / John Goold
Tel: +44 (0) 203 829 5000
Liberum Capital Limited (Joint Broker)
Tel: +44 (0) 20 3100 2222
Clayton Bush / Edward Thomas
Belvedere Communications Limited
Cat Valentine
Tel: +44 (0) 7715 769 078
Keeley Clarke
Tel: +44 (0) 7967 816 525
Llew Angus
Tel: +44 (0) 7407 023 147
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisition of a state-of-the-art tissue converter based in Leicester, the Group now operates from five sites, including four in Lancashire, which generate revenues totalling c.16% of the £1.7bn UK retail tissue market.
For more information, please visit www.accrol.com.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Gareth Jenkins
2
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Accrol Group Holdings plc
b)
LEI
213800MC56M5G69RJ226
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of £0.001 each
ISIN: GB00BZ6VT592
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
Price: £0.705
Volume: 1,333,000
d)
Aggregated information
- Aggregated volume
- Price
Price: £0.705
Volume: 1,333,000
e)
Date of the transaction
13 January 2021
f)
Place of the transaction
London Stock Exchange, AIM
1Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mark Dewhurst
2
Reason for the notification
a)
Position/status
Chief Operating Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Accrol Group Holdings plc
b)
LEI
213800MC56M5G69RJ226
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of £0.001 each
ISIN: GB00BZ6VT592
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
Price: £0.705
Volume: 444,000
d)
Aggregated information
- Aggregated volume
- Price
Price: £0.705
Volume: 444,000
e)
Date of the transaction
13 January 2021
f)
Place of the transaction
London Stock Exchange, AIM
1Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Graham Cox
2
Reason for the notification
a)
Position/status
Commercial Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Accrol Group Holdings plc
b)
LEI
213800MC56M5G69RJ226
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of £0.001 each
ISIN: GB00BZ6VT592
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
Price: £0.705
Volume: 333,000
d)
Aggregated information
- Aggregated volume
- Price
Price: £0.705
Volume: 333,000
e)
Date of the transaction
13 January 2021
f)
Place of the transaction
London Stock Exchange, AIM
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHUOSBRARUAAAR
Recent news on Accrol group
See all newsREG - Maven Inv Partners Accrol Group Hldgs - Form 8.3 - ACCROL GROUP HLDGS PLC
AnnouncementREG - Schroders PLC Accrol Group Hldgs - Form 8.3 - Accrol Group Holdings PLC
AnnouncementREG-Samson Rock Capital LLP: Form 8.3 - Accrol Group Holdings plc
AnnouncementREG - Decagon Asset Mgmt. Accrol Group Hldgs - Form 8.3 - Accrol Group Holdings Plc
AnnouncementREG - Schroders PLC Accrol Group Hldgs - Form 8.3 - Accrol Group Holdings PLC
Announcement